Inhibition of transforming growth factor-β/Smad signaling improves regeneration of small-for-size rat liver grafts

Liver Transplantation

Volumn 16, Issue 2, 2010, Pages 181-190

  Zhong, Zhi ^a   Tsukada, Shigeki ^c   Rehman, Hasibur ^a   Parsons, Christopher J ^c   Theruvath, Tom P ^a   Rippe, Richard A ^c   Brenner, David A ^d   Lemasters, John J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BILIRUBIN; BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 1; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADENOVIRUS; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DONOR; GENE OVEREXPRESSION; IMPLANTATION; LIVER GRAFT; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECIPIENT; SIGNAL TRANSDUCTION; SURGICAL TECHNIQUE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE TRANSFER TECHNIQUES; LAC OPERON; LIVER REGENERATION; LIVER TRANSPLANTATION; ORGAN SIZE; RATS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 75449109351     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21966     Document Type: Article

References (58)

1. Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split-liver transplantation in the United States: outcomes of a national survey. Ann Surg 2004;239:172-181.
2. Strong RW. Living-donor liver transplantation: an overview. J Hepatobiliary Pancreat Surg 2006;13:370-377.
3. Sugawara Y, Makuuchi M, Takayama T, Imamura H, Dowaki S, Mizuta K, et al. Small-for-size grafts in livingrelated liver transplantation. J Am Coll Surg 2001;192: 510-513.
4. Tian Y, Graf R, Jochum W, Clavien PA. Arterialized partial orthotopic liver transplantation in the mouse: a new model and evaluation of the critical liver mass. Liver Transpl 2003;9:789-795.
5. Zhong Z, Schwabe RF, Kai Y, He L, Yang L, Bunzendahl H, et al. Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of JNK, cyclin D1 and defective energy supply. Transplantation 2006;82:241-250.
6. Rehman H, Connor HD, Ramshesh VK, Theruvath TP, Mason RP, Wright GL, et al. Ischemic preconditioning prevents free radical production and mitochondrial depolarization in small-for-size rat liver grafts. Transplantation 2008;85:1322-1331.
7. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213:286-300.
8. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43:S45-S53.
9. Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration. Gut 2000;47:309-312.
10. Scotté M, Masson S, Lyoumi S, Hiron M, Ténière P, Lebreton JP, Daveau M. Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine 1997;9:859-867.
11. Bissell DM, Wang S, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995;96:447-455.
12. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factorbeta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985;133:1042-1050.
13. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor beta. Biochim Biophys Acta 1990;1032:79-87.
14. Lonn P, Moren A, Raja E, Dahl M, Moustakas A. Regulating the stability of TGFbeta receptors and Smads. Cell Res 2009;19:21-35.
15. Derynck R. TGF-beta-receptor-mediated signaling. Trends Biochem Sci 1994;19:548-553.
16. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997;16:5353-5362.
17. Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 2009;19:128-139.
18. Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 2001;91: 1-34.
19. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997; 389:631-635.
20. Tsukada S, Westwick JK, Ikejima K, Sato N, Rippe RA. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. J Biol Chem 2005;280:10055-10064.
21. Zhong Z, Froh M, Wheeler MD, Smutney O, Lehmann TG, Thurman RG. Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat. Gene Ther 2002;9:183-191.
22. Omura T, Ascher NL, Emond JC. Fifty-percent partial liver transplantation in the rat. Transplantation 1996;62:292-293.
23. Zhong Z, Connor HD, Froh M, Bunzendahl H, Lind H, Lehnert M, et al. Free radical-dependent dysfunction of small-for-size rat liver grafts: prevention by plant polyphenols. Gastroenterology 2005;129:652-664.
24. Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol Cell 1999;4:499-509.
25. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-704.
26. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;11:211-219.
27. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 2002;82:85-91.
28. Robson CN, Gnanapragasam V, Byrne RL, Collins AT, Neal DE. Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. J Endocrinol 1999;160:257-266.
29. Zhong Z, Theruvath TP, Currin RT, Waldmeier PC, Lemasters JJ. NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver grafts. Am J Transplant 2007;7:1103-1111.
30. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994;19:489-497.
31. Fitzgerald MJ, Webber EM, Donovan JR, Fausto N. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ 1995;6: 417-427.
32. Asakura T, Ohkohchi N, Satomi S. Changes of serum cytokines associated with hepatic regeneration after living-related liver transplantation. Transplant Proc 2000; 32:2199-2203.
33. Ninomiya M, Harada N, Shiotani S, Hiroshige S, Minagawa R, Soejima Y, et al. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation. Transpl Int 2003;16:814-819.
34. Tian Y, Jochum W, Georgiev P, Moritz W, Graf R, Clavien PA. Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse. Proc Natl Acad Sci U S A 2006;103: 4598-4603.
35. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
36. Biasi F, Mascia C, Poli G. TGFbeta1 expression in colonic mucosa: modulation by dietary lipids. Genes Nutr 2007; 2:233-243.
37. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008;10:333-342.
38. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791.
39. Piek E, Heldin CH, Ten DP. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999; 13:2105-2124.
40. Heldin CH, Miyazono K, Ten DP. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-471.
41. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett 2006;580:2811-2820.
42. Attisano L, Wrana JL. Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev 1996;7:327-339.
43. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with Smads. J Biol Chem 1999;274: 35269-35277.
44. Wan Y, Liu X, Kirschner MW. The anaphase-promoting complex mediates TGF-β signaling by targeting SnoN for destruction. Mol Cell 2001;8:1027-1039.
45. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M. TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 2001;3:587-595.
46. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 1999;286:771-774.
47. Roberts JM, Koff A, Polyak K, Firpo E, Collins S, Ohtsubo M, Massagué J. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harb Symp Quant Biol 1994;59:31-38.
48. Morgan DO. Principles of CDK regulation. Nature 1995; 374:131-134.
49. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev 1995;9:1149-1163.
50. Nelsen CJ, Rickheim DG, Timchenko NA, Stanley MW, Albrecht JH. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res 2001;61:8564-8568.
51. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371:257-261.
52. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
53. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
54. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
55. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54:1169-1174.
56. Alpan RS, Pardee AB. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ 1996;7:893-901.
57. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994;54:3391-3395.
58. Man K, Lo CM, Xiao JW, Ng KT, Sun BS, Ng IO, et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 2008;247:1049-1057.